You just read:

Theravance Biopharma Highlights GlaxoSmithKline and Innoviva's Receipt of Positive Opinion from CHMP in Europe for Trelegy Ellipta (Closed Triple)

News provided by

Theravance Biopharma, Inc.

Sep 18, 2017, 08:30 ET